Back to top
more

Anthem, Inc. (ANTM)

(Delayed Data from NYSE)

$261.70 USD

261.70
1,184,666

+0.11 (0.04%)

Updated May 3, 2019 04:00 PM ET

After-Market: $261.69 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Based in Indianapolis, IN, and formed through the merger of Anthem Inc. and WellPoint Health Networks Inc. in Nov 2004, Anthem Inc. is one of the largest publicly traded managed care organizations in terms of membership. The company was previously named WellPoint Inc. (WLP). The company is also an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Anthem is the largest BCBS plan provider in the United States. As of Mar 31, 2020, it catered to 42.1 million medical members through its affiliated health plans.

What's in the Cards for Anthem's (ANTM) Earnings in Q1?

by Zacks Equity Research

Anthem's (ANTM) Q1 earnings results are likely to reflect higher revenues, backed by its Government and Commercial & Specialty businesses.

Humana (HUM) Gears up for Earnings in Q1: What to Expect

by Zacks Equity Research

Humana's (HUM) Q1 earnings results are likely to reflect growth in revenues, which in turn, are expected to have been driven by its Medicaid and Medicare businesses.

Will Dismal North American Market Hurt Ford's (F) Q1 Earnings?

by Zacks Equity Research

Declining sales in Ford's (F) North American segment likely to have hurt the company's Q1 bottom line.

Will Solid Model 3/Y Sales Drive Tesla's (TSLA) Q1 Earnings?

by Zacks Equity Research

Rise in Tesla's (TSLA) Model 3/Y deliveries likely to have fueled the company's earnings in the first quarter of 2020.

What's in the Cards for Centene's (CNC) Earnings in Q1?

by Zacks Equity Research

Centene's (CNC) Q1 results are likely to reflect escalating expenses, partially offset by higher revenues.

    Harley-Davidson (HOG) to Post Q1 Earnings: What's in Store?

    by Zacks Equity Research

    While Harley-Davidson's (HOG) efforts to bolster dealer networks is likely to have aided its revenues in Q1, high SG&A costs and rising competition remain concerns.

    What's in the Offing for Cummins (CMI) This Earnings Season?

    by Zacks Equity Research

    Heightening coronavirus fears and elevated R&D expenses are likely to have dragged down Cummins' (CMI) margins in the first quarter.

    Anthem (ANTM) Reports Next Week: Wall Street Expects Earnings Growth

    by Zacks Equity Research

    Anthem (ANTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Universal Health's (UHS) Q1 Earnings: What is in Store?

    by Zacks Equity Research

    Universal Health's (UHS) first-quarter results are likely to reflect better revenues, partially offset by the COVID-19 impact.

    What's in the Offing for Tesla (TSLA) This Earnings Season?

    by Zacks Equity Research

    While increasing Model 3 deliveries are likely to have aided Tesla's (TSLA) revenues in the first quarter, rising R&D and SG&A costs are concerns.

    How Badly Will Coronavirus Hit Ford's (F) Q1 Earnings?

    by Zacks Equity Research

    Amid coronavirus outbreak and stay-at-home orders in multiple states, Ford (F) anticipates a net loss of $2 billion in the first quarter of 2020.

    Sapna Bagaria headshot

    HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact

    by Sapna Bagaria

    Health Insurers are likely to gain from higher demand for its products and services from senior citizens and the rising incidence of illness, partially offset by the COVID-19-led fallout.

    HCA Healthcare's (HCA) Earnings Miss in Q1, Decrease Y/Y

    by Zacks Equity Research

    HCA Healthcare's (HCA) Q1 earnings take a hit from the coronavirus outbreak inducing lower patient volumes.

      O'Reilly (ORLY) to Post Q1 Earnings: What's in the Offing?

      by Zacks Equity Research

      Elevated SG&A costs, along with weak demand of vehicles due to the coronavirus outbreak, are likely to have eroded O'Reilly's (ORLY) margins in Q1.

      PACCAR (PCAR) Gearing Up for Q1 Earnings: What to Expect?

      by Zacks Equity Research

      Low orders for Class 8 trucks due to the outbreak of coronavirus are likely to have dented PACCAR's (PCAR) first-quarter 2020 revenues.

      Teladoc Q1 Preliminary Results Gain From Coronavirus-Led Demand

      by Zacks Equity Research

      The rising adoption of telehealth services prompted by the coronavirus breakdown boosts Teladoc Health's (TDOC) business operations.

      HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?

      by Zacks Equity Research

      HCA Healthcare's (HCA) Q1 results are likely to reflect weak volumes from the coronavirus effect.

      Molina Healthcare Gains on Sanders' Exit From Presidential Race

      by Zacks Equity Research

      Molina Healthcare (MOH) gains from Bernie Sanders' withdrawal from the presidential campaign.

      UnitedHeath (UNH) Beats on Q1 Earnings, Dodges Coronavirus Curse

      by Zacks Equity Research

      UnitedHealth's (UNH) Q1 earnings benefit from higher contribution at both its segments, escaping the fallout from the coronavirus-led crisis.

      The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health

      The Zacks Analyst Blog Highlights: Teladoc Health, Anthem, CVS Health and Humana

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: Teladoc Health, Anthem, CVS Health and Humana

      The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana

      7 Health Insurers Poised to Beat Earnings Estimates in Q1

      by Zacks Equity Research

      Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.

      4 Telehealth Stocks Amid Coronavirus-Led Lockdown

      by Zacks Equity Research

      Telemedicine has emerged as the need of the hour for homebound Americans seeking medical expertise because of the pandemic.

      Centene Soars 47.8% in Six Months: Will the Rally Continue?

      by Zacks Equity Research

      Centene's (CNC) strategic initiatives and higher membership might aid its revenues to perk up its share price in turn.